The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Warner Chilcott Public Limited Company

Warner Chilcott Public Limited Company
 PROFILE
Warner Chilcott is focused on making women's health care and urology prescription drugs; it also makes dermatology and cardiology drugs. The company has development and marketing relationships with such partners as Irish drugmaker (and former parent) Elan, Bristol-Myers Squibb, and Schering-Plough. Its branded drugs include estrogen replacement Estrace (bought from Bristol-Myers Squibb), oral contraceptive Ovcon 35, cholesterol-lowering LoCholest, and prenatal multivitamin NataFort. Once a generics developer, Warner Chilcott plans to sell the 10 or so drugs remaining in its generics line. Galen Holdings acquired the company in 2000.

 COMPETITION
Aventis (AVE)
Bristol-Myers Squibb Company (BMY)
Johnson & Johnson (JNJ)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 74.00
1-Yr. Sales Growth: 14.2%
Employees: 313
Revenue per employee: $236,421.73

 KEY PEOPLE

• R. Geoffrey Elliott
    CFO

 CONTACT INFO
Rockaway 80 Corporate Center
Rockaway, NJ 07866
US
Phone: 973-442-3200
Fax: 973-442-3283
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001